Mosquito allergy can rarely give raise to severe clinical
manifestations.Here we describe the case of a patient suffering from
relapsing anaphylaxis after mosquito bites, who completely responded to
off label therapy with anti-IgE monoclonal antibody.This is the first
demonstration of the efficacy of omalizumab in such unusual
life-threatening allergy.